HOME >> MEDICINE >> NEWS
Are one-third of costly implanted heart devices unnecessary? New study suggests yes

ANN ARBOR, Mich. -- This year, Medicare will pay for tens of thousands of heart patients to have high-tech devices implanted in their chests. Called ICDs or implantable cardioverter defibrillators, the expensive devices are designed to shock damaged hearts back into rhythm and save patients from sudden cardiac death, which kills 300,000 Americans each year.

But a new study finds that while many of these patients will benefit from their ICDs, a large number won't -- and a simple heart-rhythm test can tell who's who.

In fact, the study suggests that if the test were used on the majority of ICD candidates, as many as one-third could be spared the operation to implant a device, without raising their risk of sudden death. That would mean that Medicare could be spared the additional $90,000 lifetime cost of each device compared to best medical therapy.

The study, published in the January issue of the Journal of the American College of Cardiology, is based on data from 768 patients who were candidates for ICDs at Christ Hospital and the Ohio Heart and Vascular Center in Cincinnati. All of the patients had survived heart attacks but had permanent damage to their heart muscle caused by lack of blood flow -- a condition called ischemic cardiomyopathy.

Each patient received a test called microvolt T-wave alternans or MTWA, along with a battery of other tests, during their evaluation. Half of the patients went on to receive ICDs, although the MTWA test results weren't used in the decision-making process. The patients' health and the causes of any deaths were tracked for up to three years.

After that time, the data were analyzed by researchers from the University of Michigan Cardiovascular Center and VA Ann Arbor Healthcare System, in cooperation with the Ohio team.

In all, 67 percent of patients had positive or inconclusive MTWA test results. Of them, the patients who went on to receive an ICD were 55 percent less
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
3-Jan-2007


Page: 1 2 3

Related medicine news :

1. New study: Preterm birth causes one-third of all infant deaths
2. More than one-third of disaster victims may suffer from stress disorder
3. HIV infection rates down one-third in south India, University of Toronto study
4. Traditional risk-factor scoring misses one-third of women vulnerable to coronary heart disease
5. Only one-third of women take vitamin to help prevent serious birth defects, survey finds
6. Resident work hour restrictions may be costly for teaching hospitals
7. ADHD costly before and after diagnosis
8. Oops! Researchers publish new findings on the brains response to costly mistakes
9. Headlines about Herceptin show equality of access to costly drugs must be tackled
10. Bipolar disorder more prevalent and costly than believed; Lithium could curb suicide rate
11. Prescription of heroin is less costly for society

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... Ontario (PRWEB) , ... August 07, 2020 , ... ... the AGCO with the assistance of dicentra Cannabis Consulting . , The ... on May 31st. It is the first of many locations as the company plans ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... repeatedly risen to unprecedented challenges. Regardless of the obstacle - shortages of tests, ... equipment (PPE) and the cancellation or postponement of all nonessential services - providers ...
(Date:8/5/2020)... ... ... CentrAlert, Inc. today announced the launch of their free Know ... which is available for Apple and Android , seeks to streamline ... , “When COVID-19 first hit, there was so much that we didn’t know,” says ...
(Date:8/5/2020)... ... ... Today, Power to Decide’s One Key Question was recognized by the Association ... Award. The One Key Question program is a transformative tool that starts the conversation ... One Key Question is used by thousands of health care, social service providers and ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate ... first patients with first-line advanced pancreatic cancer in a phase 2 study of ... 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... ROCKVILLE, Md. (PRWEB) , ... August 04, 2020 ... ... audiology and speech-language pathology therapy services vital to their health and quality of ... to protect them, the American Speech-Language-Hearing Association (ASHA) warns today. ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... Business Continuity Emergency Operations Planning services for small business owners. These ... unable to manage or communicate with their teams for 30-90 days as a ...
(Date:7/31/2020)... ... July 31, 2020 , ... Innovative Health, Inc. ... Medical BRK Transseptal Needle and the Baylis Medical NRG Transseptal Needle. Innovative Health’s ... reprocessing, as no other company is able to offer reprocessed transseptal needles and ...
Breaking Medicine Technology:
Cached News: